综合微生物组数据分析揭示了ICU患者潜在的肺炎微生物标志物:机器学习方法
Pownraj Brindangnanam1, Mohane Selvaraj Coumar2
1Department of Bioinformatics, School of Life Sciences, Pondicherry University, Kalapet, Pondicherry, 605014, India.
Current microbiology
|August 30, 2025
概括
这项研究确定Pseudomonas是重症监护室 (ICU) 患者肺炎的关键微生物生物标志物. 针对特定的功能途径可以提供新的精准医学策略来管理这种常见的ICU感染.
科学领域:
- 微生物学
- 医学科学
- 计算生物学
背景情况:
- 人类微生物组在健康和疾病中起着至关重要的作用.
- 肺炎是重症监护室 (ICU) 的重要感染.
- 人们越来越认识到内吸附体 (ETA) 微生物群对肺炎发展的影响.
研究的目的:
- 研究肺炎的重症监护室患者的核心微生物组.
- 确定与肺炎相关的微生物和功能生物标志物.
- 探索肺炎管理的潜在精准医学目标.
主要方法:
- 对ICU患者肺部微生物群的16S rRNA测序数据的分析.
- 应用机器学习模型 (xgbTree) 进行预测分析.
- 鉴定到的微生物群落的功能分析.
主要成果:
- 被确定为肺炎的关键微生物生物标志物.
- 一个机器学习模型实现了高预测精度 (prAUC:0.98).
- 作为潜在的分子标,突出显示了ATP结合盒 (ABC) 载体和抗四环素的核糖体保护蛋白 (Tet RPPs).
结论:
- 肺炎在重症监护室中表现出特定的微生物特征.
- 伪菌可以作为肺炎的潜在诊断标志物.
- 与抗生素耐药性相关的功能途径为肺炎治疗的可行目标.
更多相关视频
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
12.0K
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
9.0K
相关概念视频
Pneumonia III: Complications and Assessment
432
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
432
Pneumonia I: Introduction
326
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
326
Pneumonia II: Pathophysiology
542
The pathophysiology of pneumonia involves the following steps:
542
Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445
MALDI-TOF Mass Spectrometry
5.2K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
5.2K
